Advanced search
Publication Cover
Leukemia & Lymphoma Volume 35, 1999 - Issue 5-6
Submit an article Journal homepage
25
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Interferon-α and Bcr-Abl Antisense Oligodeoxynucleotides in Combination Enhance the Antileukemic Effect and the Adherence of CML Progenitors to Preformed Stroma

Roberto Bellucci Dipartimento di Biotecnologie Cellulari ed Ematologia, University “La Sapienza”, Rome, Italy
,
Roberta Sala Dipartimento di Biotecnologie Cellulari ed Ematologia, University “La Sapienza”, Rome, Italy
,
Maria Stefania de Propris Dipartimento di Biotecnologie Cellulari ed Ematologia, University “La Sapienza”, Rome, Italy
,
Iole Cordone Dipartimento di Biotecnologie Cellulari ed Ematologia, University “La Sapienza”, Rome, Italy
&
Paolo de Fabritiis Dipartimento di Biotecnologie Cellulari ed Ematologia, University “La Sapienza”, Rome, ItalyCorrespondence[email protected]
Pages 471-481 | Received 30 Mar 1999, Published online: 30 Mar 2010

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

T Kindler, RG Meyer & T Fischer. (2002) BCR-ABL as a target for novel therapeutic interventions. Expert Opinion on Therapeutic Targets 6:1, pages 85-101.
Read now

Articles from other publishers (4)

Barbara DapasLaura PerissinCarlo PucilloFranco QuadrifoglioBruna Scaggiante. (2002) Increase in Therapeutic Index of Doxorubicin and Vinblastine by Aptameric Oligonucleotide in Human T Lymphoblastic Drug-Sensitive and Multidrug-Resistant Cells. Antisense and Nucleic Acid Drug Development 12:4, pages 247-255.
Crossref
Robert P. Hasserjian, Federica Boecklin, Sally Parker, Andy Chase, Sunanda Dhar, Michael Zaiac, Eduardo Olavarria, Irvin Lampert, Kristin Henry, Jane F. Apperley & John M. Goldman. (2002) STI571 (Imatinib Mesylate) Reduces Bone Marrow Cellularity and Normalizes Morphologic Features Irrespective of Cytogenetic Response. American Journal of Clinical Pathology 117:3, pages 360-367.
Crossref
Balkrishna N Jahagirdar, Jeffrey S Miller, Arun Shet & Catherine M Verfaillie. (2001) Novel therapies for chronic myelogenous leukemia. Experimental Hematology 29:5, pages 543-556.
Crossref
W. Pawlak, J. Zolnierek, T. Sarosiek & C. Szczylik. (2000) Antisense therapy in cancer. Cancer Treatment Reviews 26:5, pages 333-350.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.